Here we describe the use of an organotypic hippocampal slice model for studying α-synuclein aggregation and inter-neuronal spreading initiated by injection of preformed α-synuclein filaments (PFFs). PFF injection at dentate gyrus templates the endogenous α-synuclein to form aggregates in axons and cell bodies that spread to CA3 and CA1 regions. Aggregates were insoluble and phosphorylated at serine 129, recapitulating Lewy pathology features found in Parkinson's disease and other synucleinopathies. The spreading of the aggregates were favoring the anterograde direction in the slice model. The model allowed development of slices expressing only serine-129 phosphorylation-deficient human α-synuclein (S129G) using adeno-associated viral (AAV) vector in α-synuclein knockout slices. Processes of aggregation and spreading of α-synuclein were thereby shown to be independent of phosphorylation at serine 129. We provide methods and highlight crucial steps for PFF microinjection and characterization of aggregate formation and spreading. Slices derived from genetically engineered mice or manipulated by using viral vectors allow testing of hypotheses on mechanisms involved in formation of α-synuclein aggregates and their prion-like spreading.
3 mice (Tg(Thy1-SNCA)61Ema) (Rockenstein et al., 2002) according to Stoppini et al. 1991 (Stoppini, Buchs, & Muller, 1991) . Low Na cerebrospinal fluid (CSF) was carbogenated on ice until the color changed to orange and some ice slashes were formed (1 mM CaCl2, 10 mM D-glucose, 4 mM KCl, 5 mM MgCl2, 26 mM NaHCO3, 234 mM sucrose and 0.1% phenol red solution). 15 ml of low Na CSF was prepared for each brain in a 50ml Falcon tube. After decapitation of the pups, the extracted brain was moved gently and kept in low Na CSF for 1 minute, before the brain and the low Na CSF were poured gently into a petri dish for hippocampus dissection under microscopic guidance (SZX-ZB7 Stereomicroscope, Olympus x1 objective).
Slices of 400 µm thickness were made using a tissue chopper (Stoelting, #51425) before being moved to a culture medium (MEM Eagle medium 78.8% (Gibco #11095), 20% heat-inactivated horse serum (Gibco, #16050-122), 1 mM L-glutamine,1 mM CaCl2, 2 mM MgSO4, 170 nM insulin, 0.0012% ascorbic acid, 12.9 mM D-glucose, 5.2 mM NaHCO3, 300 mM Hepes (Sigma #H3375), pH=7.28, osmolality adjusted to 317-322) pre-heated to 37°. Only slices with intact DG and CA regions were selected under the microscope and moved to air-fluid interface-style Millicell culture inserts, 30 mm diameter, 0.4 µm (Millipore) in 6-well culture plates (ThermoFisher Scientific) with 800 µL of sterile medium added below the insert (Stoppini et al., 1991) . The full medium was changed trice weekly. All steps of the procedure after decapitation and brain extraction were performed in a laminar flow tissue culture hood using sterile equipment and aseptic technique.
Preparation of S129A α-syn pre-formed fibrils (PFFs)
Recombinant human α-syn with residue serine129 to an alanine was expressed in E. coli and purified as described in wild type α-syn (Huang, Ren, Zhou, & Wang, 2005) . To make pre-formed S129A-α-syn PFFs, monomeric S129A α-syn (5 mg/ml) in Eppendorf tubes was incubated in sterile phosphate-buffered saline (PBS), pH 7.4 (Gibco), for 48 hours at 37°C on a Thermomixer (Eppendorf) at 1050 rpm. To validate sufficient aggregation, 50 µl of the incubate was centrifuged at 25,000 × g for 20 min and the supernatant was isolated.
PBS, 50 µl, was added on the pellet and 50 µl 2 x SDS-loading buffer (20 mM Tris, pH 6.8, 2 mM EDTA, 80 mM DTT, 2% SDS, 20% sucrose) was added to the pellets and supernatants, which were heated to 96°C for 15 min. Equal volumes of supernatants and pellets were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis on 8-16% Bis-Tris gels (Genscript) that subsequently were stained with Coomassie blue R-250 ( Supplementary fig. 1,a,i) . Approximately 75% of the protein was routinely recovered in the insoluble pellet fraction. To ascertain the development of amyloid-type aggregates in the insoluble fractions, K114 fluorometry was conducted (Crystal et al., 2003) . Equal volumes of aggregated and monomer α-syn S129A were mixed with the (trans,trans)-1-bromo-2,5-bis-(4-hydroxy)styrylbenzene (K114) (50 µM) in 100 mM glycine, pH 8.5, after which fluorescence (λex=380 nm, λem=550 nm, cutoff = 530 nm)
was measured with a Perkin Elmer, EnSpire 2300 Multilabel Reader (Supplementary fig. 1 ,a,ii).
When proper aggregation had been assured, the insoluble S129A α-syn was isolated by centrifugation in Eppendorf tubes. After discarding the supernatant, the pellet containing the PFFs was diluted to 2 mg/ml in sterile PBS, pH 7.4 (Gibco) and subjected to ultrasound breakage for 20 min using a sonicator (Branson 250, settings: 30% Duty Cycle, Output Control 3) equipped with a water jacket cooling system to avoid sample heating during sonication. The size distribution profile of the PFFs was measured using dynamic light scattering (DLS) using a Wyatt DynaPro NanoStar instrument at 25°C. Data were processed using the Dynamics 7.5.0.17 software package with the solvent (PBS) background signal subtracted from each sample.
The PFF sample showed a homogeneous, monodispersed population with a hydrodynamic radius of 44 nm ( Supplementary fig. 1 ,a,iii). The PFFs were dispensed into sterile Eppendorf tubes in (75 µl) aliquots of concentration, 2mg/ml, snap frozen and stored at −80 ° C. A sample was used to validate the protein concentration using BCA analysis.
Microinjection of organotypic slices
To facilitate injection, each insert was moved from the 6-well plate to a sterile cell culture dish, 35 x 10 mm (SARSTEDT #83.3900.500), before injection. Slices were microinjected in the DG after 7 days in culture, except where otherwise mentioned. Light microscopy was used to identify DG by a characteristic horseshoe arrangement of the nuclei of granule cells.
Immediately before injection, the aliquot of S129A PFFs was thawed at room temperature (RT) and sonicated for 30 seconds using the above settings (Branson, Sonifier 250). After sonication, PFFs were kept at RT during the injection process. Microinjection pipette (item #1B200F-4 (with Filament), WPI) was pulled using a micropipette puller (P-1000, Sutter Instrument). For microinjection, a Pulse Pal v2 (#1102) was used (settings: phase 1 voltage 5V, phase 1 duration 0.01 seconds, pulse interval 0.5 seconds).
Injections were performed in a laminar flow hood equipped with a microscope to ensure aseptic conditions. The pipette was loaded using Eppendorf microloader pipette tips (ThermoFisher); the pipette was inserted into the holder, and the tip was cut with a fine scissor under visual guidance. Pressure pulse was applied to test whether the PFF suspension was expelled from the tip. Once the tip was open, a small droplet should emerge.
Correct injection was confirmed by short lifting of the surface of the tissue at the injection site. After injection, the needle was left in place for 20 seconds and then slowly removed. The volume injected in the slices was estimated by counting the number of shots with the adjusted Pulse Pal set up (10-12 shots/slice, 10 nl/shot, 0.1 μg/slice). The final volume was injected at the DG at two to three injection sites depending on the slice thickness at the site of needle insertion. It was important to pay attention to tissue architecture under microscopic guidance during the injection procedure to avoid injection of a large volume at a single site which would cause rupture of the tissue and release of the PFFs to the surface of OHCS. The session lasted approximately 6 to 8 minutes for an insert holding four slices. The final volume injected in each slice was 5 about 0.1µl of either S129A-PFF (1 mg/mL), monomeric α-syn (1 mg/mL), or PBS. After injecting all slices on a culture insert, the medium was replaced with a fresh pre-heated medium.
Adeno-associated viral (AAV) mediated expression of wt and S129G α-syn in slices from α-syn KO mice
Pseudotyped rAAV2/6 WT human α-syn and rAAV2/6 S129G human α-syn vectors were produced by using a co-transfection method with rAAV transfer plasmid containing the gene of interest placed between two AAV2-inverted terminal repeats and a helper plasmid (pDP6) coding for necessary elements for production and packaging of the capsid particles. The gene of interest was driven under the control of a human synapsin-1 promoter. Vectors were purified by iodixanol step gradients and ion exchange chromatography, as described in detail elsewhere (Zolotukhin et al., 2002) . The final titers used in the experiments were 3.5 x 10E13 genome copy (gc)/ml. All titers were determined by quantitative PCR using TaqMan probes targeting the ITR sequences. After 3 days in culture, AAV-human-α-syn and AAV-human-S129G-α-syn vectors were injected in slices made from P5 α-syn KO pups. The slices were either injected with the virus at the three regions DG, CA3, and CA1 or only at DG and CA1. This procedure expresses α-syn either in the three synaptically connected regions or leaves the interconnecting CA3 region without α-syn expression. Three days after AAV injection, α-syn S129A PFFs were injected at DG as demonstrated in Fig. 3c,d .
Immunohistochemistry
Organotypic slices were fixed using 4% PFA in phosphate buffer (PB) (2.8 mM NaH2PO4H2O, 7.2 mM Na2HPO4.2H2O, 123 mM NaCL, pH adjusted to 7.2) and processed for immunohistochemistry according to Gogolla et al., with slight modifications (Gogolla, Galimberti, DePaola, & Caroni, 2006) . Briefly, after fixation, slices were permeabilized using 0.5% Triton X-100 for 6 hours at RT or overnight at 4°C with slight shaking. Slices were then incubated with blocking buffer (10% bovine serum albumin (BSA)/PB) for 3 hours at RT. The primary antibody was prepared in 5% BSA/PB and incubated with slices overnight at 4°C during gentle shaking. Antibodies used were α-syn aggregate-specific antibody MJF14 (rabbit monoclonal MJFR-14-6-4-2. Abcam,1:25,000), the two phospho-serine129-specific antibodies, 11A5 (Anderson et al., 2006) (mouse monoclonal 11A5 kindly provided by Imago Pharmaceuticals, 1:25,000) and D1R1R (rabbit mAb #20706S, Cell signaling. 1:1000), NF-L (mouse mAb #2835, Cell signaling. 1:500) NeuN (mouse mAb clone A60, Millipore. 1:200), and anti-alpha-synuclein antibody MJFR1 (rabbit monoclonal ab138501, Abcam, 1:5000). The slices were washed trice using TBS (NaCl 150 mM, Tris 20 mM) with 0.3% Triton X-100 washing buffer during gentle shaking for 30 minutes/wash. After the final wash, the slices were incubated with the appropriate Alexa Fluor dye (488 and 568) labeled secondary antibody (Invitrogen 1:2000) and 4',6 diamidino-2 phenylindole (DAPI) (TH.GEYER, 5 mg/mL, 1:1000) in 5% BSA/PB for 3 hours at RT during 6 gentle agitation shielded from light. The slices were washed trice as above and mounted using DAKO mounting medium (DAKO, D3023). The edges of the coverslip were sealed using nail polish.
The staining could be done either by i) directly adding reagents to the inserts (1ml about and 1ml below the insert) or ii) excising the slices from the inserts with their culture membrane below with a scalpel and further incubating them with antibodies in 96-well plates to save reagent. For the washing steps, 24-well plates were used to ensure proper rinsing.
Preparation of the organotypic hippocampal slice culture for super-resolution dSTORM imaging
For cryosection, 4% PFA-fixed slices were kept in 30% sucrose at 4°C overnight for cryoprotection.
The slices were cut out of the membrane insert with a piece of membrane below. Holding the slice carefully from the membrane, the slices were mounted on the cryostate stage using Tissue-Tek® O.C.T. Compound (Sakura), where the slice surface faces downwards. After the OCT solidified, the membrane was carefully removed and an extra amount of OCT was added on top of the slice and cut on cryostate (Leica) at a thickness of 10 µm at -20 °C. The sections were collected on Superfrost Plus Adhesion Microscope Slides (ThermoFisher). Immunostaining was processed on the slides as previously described for the whole mount using an antibody against pS129. During antibody incubation, slides were kept in a humidity chamber with a hydrophobic pen barrier erected around the tissue to prevent it from drying out during incubation. After the final washing step, the slides were mounted using glycerol gelatin aqueous slide mounting medium (Sigma).
Tissue preparation for super-resolution dSTORM imaging:
Stained tissue slices were gelatin-embedded and sandwiched between a rectangular coverslip (50 X 24 mm) and microscope slide (75 X 25 mm). To facilitate dSTORM imaging, conventional dSTORM imaging buffer (50 mM Tris/HCl pH 8, 10 mM NaCl, 10% (w/v) D-Glucose, 500 µg/mL glucose oxidase, 40 µg/mL glucose catalase and 35 mM MEA in H2O) was added to the embedded slice. The rectangular coverslip was carefully removed by immersing the microscope slide into a beaker of PBS prewarmed to 60 °C. Imaging buffer (100 uL) was added to the gelatin layer, and a new rectangular coverslip was then placed over the gelatin layer.
The coverslip edges were then sealed using a 2-component silicon glue. Once the glue was set, the coverslip and the microscope slide sandwich were mounted on a microscope stage for imaging.
Microscope setup for dSTORM acquisition:
dSTORM image acquisition was performed on a custom-built inverted microscope. Laser light at 405 nm and 640 nm wavelengths emitted from a laser box equipped with a single-mode fiber (iChrome MLE, Toptica) was collimated using an achromatic lens (f = 30 mm, Thorlabs), relayed by a 4f microscope of two lenses (each f = 250 mm, Thorlabs), spatially filtered for background reduction by an iris conjugate to the image plane (SM1D12D, Thorlabs), and focused onto the back-focal plane of a water-immersion objective lens (60x 7 / NA1.2, Olympus). Mounting the fiber on a one-axis stage (SLC2445me-4, Smaract) allowed for image acquisition in HILO (highly inclined and laminated optical sheet) mode (Tokunaga, Imamoto, & Sakata-Sogawa, 2008) . Fluorescence excitation and emission were separated using a multi-line dichroic beam splitter (zt405/488/561/640rpc, Chroma). Fluorescence emission was additionally filtered by a band pass filter (676/37 BrightLine HC, AHF) and directly focused onto an sCMOS camera (Orca Flash 4.0, Hamamatsu) via a tube lens (f = 180 mm, MVX-TLU, Olympus) resulting in projected pixel widths of 108 nm. Raw dSTORM data were recorded at a frame rate of 40 Hz and 25 msec exposure time. The lasers were triggered using an FPA (Mojo, Embedded Micro) controlled by a custom-written Micro Manager 1.4.22 plugin (Mund et al., 2018) . This kept the number of activated emitters per frame approximately constant to a preset value via modulation of the pulse length of the 405 nm laser. The intensity of the fluorescence excitation laser at 640 nm was about 10 kW/cm^2.
Immunoblotting analysis of brain slice extracts
Slices were collected by cutting the tissue with a piece of its supporting culture insert membrane to ensure that all tissue was collected. For each time point, eight slices were collected. After 14 days in culture (7dpi of the PFFs), around 30 μg of protein was extracted per slice.
After washing twice in Hank's buffer (5.37 mM KCL, 0.44 mM KH4PO4, 0.44 mM Na2HPO4, 136.9 mM NaCL), the tissue was homogenized with a tissue homogenizer (VWR #4320202) in ice-cold radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris (pH 7.4), 150 mM NaCl, 1% Triton X-100, 2 mM EDTA, 0.5% sodium deoxycholate, 0.1% SDS) supplemented with protease inhibitor cocktail (Complete, Roche) and phosphatase inhibitors (25 mM B-glycerolphosphate, 5 mM NaF, 1 mM Na3VO4, 10 mM Napyrophospate). After homogenization, samples in Eppendorf tubes were sonicated (Branson, Sonifier 250, settings: 30% Duty Cycle, Output Control 3, 40 shots) before centrifugation at 25,000 x g for 25 min at 4°C. Supernatants were collected as the RIPA-soluble fraction. The pellets were resuspended in RIPA buffer, which was washed twice by centrifugation to remove remaining soluble material from the insoluble pellets. The pellets were dissolved in SDS-urea buffer (4% SDS, 50 mM Tris, 7 M urea, 40% glycerol and bromophenol blue, 2.5 mM DTE) overnight at RT as the RIPA-insoluble aggregate fraction. Protein concentration was measured using the bicinchoninic acid assay (BCA) kit (Sigma).
The RIPA-soluble fraction lysates were supplemented with an SDS-PAGE loading buffer (50 mM Tris pH 6.8, 4% SDS, 2.5 mM DTE, 40% glycerol, bromophenol blue), whereas the RIPA-insoluble fraction was ready for loading on the gel. Samples were heated to 95°C for 5 min and resolved on 8-16% Bis-Tris gels (Genscript) before being transferred to PVDF membranes using the Iblot2 Dry blotting system (ThermoFishcer).
Membranes were fixed in 4% PFA for 30 minutes and blots probed for α-syn were boiled in PB for 10 minutes to improve immunodetection of α-syn (Lee & Kamitani, 2011) . Membranes were blocked for 1 hour at RT in blocking buffer (5% skimmed milk powder, 20 mM Tris base, 150 mM NaCl, 0.05% Tween 20-containing phosphatase inhibitors) supplemented with 0.02 % NaN3. Primary and secondary antibodies were diluted in blocking buffer. Incubation with the primary antibody was done overnight at 4°C and with secondary antibodies (DAKO #P0217, #P0260) for 1.5 hours at RT with washing in TBS-Tween trice for 15 minutes each after each incubation. Bound antibodies were visualized using enhanced chemiluminescence (ECL) in a Fuji LAS-3000 Intelligent Dark Box (Fujifilm, Japan). To reprobe filters, they were stripped for bound antibodies to the PVDF membranes using Restore Western Blot Stripping Buffer (Thermoscientific, #21059) according to the manufacturer's recommendation. Membranes were then processed with blocking and antibody detection as mentioned above. Antibodies used were the following: rabbit polyclonal anti-α-syn (ASY-1) 1:1000 (Jensen et al., 2000) , rabbit monoclonal anti-α-syn antibody (MJFR1,ab138501, 1:1000), mouse monoclonal pS129-α-syn (11A5 kindly provided by Imago Pharmaceuticals, 1:2000), mAb anti-β-Tubulin III (TUJ1, T8578, Sigma, 1:5000), mAb mouse-specific α-syn (D37A6) (XP Rabbit #4179, CS 1:1000), mAb anti-α-Syn Syn-1 (BD Transduction Laboratories, 1:1000). PageRuler pre-stained protein ladder 10-180 kDa (ThermoFischer, #26616) was used as the molecular size marker.
Quantification
Quantification of Western blots was done using ImageJ (National Institutes of Health) after first assuring that the bands were not saturated. For quantification of immunostainings, four pictures covering the whole organotypic slice were taken using x10 objective, and a threshold was set where only the aggregatespecific signals were visible. The same threshold was applied to all images. For analysis, the mean fluorescence intensity (MFI) of the selected aggregate signals was quantified using ImageJ (National Institutes of Health) software. Signals were normalized to the total surface area of each slice detected using the DAPI staining. 
Statistical data and analysis

Results
Progressive accumulation of mouse α-syn in organotypic hippocampal slice cultures and efficient Cterminal truncation of injected preformed α-syn fibrils
To study α-syn aggregate pathology and its spreading in brain tissue, we developed a new ex vivo model based on the organotypic mouse hippocampal slice culture method. The slices were prepared from 5 to 7-days-old post-natal pups of wild type BL6 mice, cultivated on a membrane by the air-fluid interphase method (Stoppini et al., 1991) (Fig. 1, b) . This preparation has been extensively used for electrophysiological studies because it exhibits well-characterized synaptic connectivity between granule neurons in DG and CA3 pyramidal neurons that subsequently form synapses on CA1 pyramidal neurons (Dunwiddie & Lynch, 1978) (Fig. 1, a) .
Because endogenous expression of α-syn is a prerequisite for templating α-syn aggregate and subsequent interneuronal spreading, we first determined the development of α-syn expression in the wild type brain slices through a 21-day culture period. The cultivated slices exhibited progressive increase of total α-syn mirroring the postnatal expression in mice (Jakowec, Donaldson, Barba, & Petzinger, 2001) (Fig. 1, c) .
The phosphorylated pS129 form became detectable after 7 days, after which its level also increased (Fig.   1, c) . Based on these data, we chose to initiate the process of aggregation by PFF microinjection in the slice cultured for 7 days in vitro (DIV).
As pathological α-syn aggregates are heavily phosphorylated on S129, we used PFFs composed of S129A mutant α-syn that cannot be phosphorylated at this site. This allowed unambiguous detection of endogenous aggregates by pS129-specific antibodies that do not bind the injected S129A seeds.
The fate of the exogenous S129A-PFF injected into the brain slices was investigated using tissue from αsyn KO pups allowing us to focus on the injected material. The tissue was analyzed 2 hours, 3 days, and 7 days post injection. To facilitate quantitative immunoblotting, PFFs injected into slices were depolymerized in 7M urea/ 4% SDS loading buffer, which allowed their quantification as a monomeric band. Using the MJFR1 antibody that binds to a C-terminal epitope (118-123), (Schmid, Fauvet, Moniatte, & Lashuel, 2013) , we observed a 30% reduction after 3 days with no detectable protein remaining after 7 days. However, using Syn-1 (BD monoclonal antibody) that detects an epitope corresponding to amino acids 91 to 99 (Schmid et al., 2013) , we found that the injected PFFs remained in the tissue but as a Cterminally truncated species (Supplementary fig. 1, b) . The Syn-1 antibody did not work well for IHC analysis of the PFF-injected α-syn KO slices to localize the truncated species at 5 and 7 days post injection.
Staining with MJFR1 revealed that the injected material was confined to a small area close to the injection site in the DG regions 2 hours post injection that disappeared after 7 days as expected from the C-terminal truncation (Supplementary figs. 1, c) .
Injection of S129A-PFF template α-syn aggregation in organotypic hippocampal slice culture When S129A-PFFs were microinjected into the tissue slice from wild type (C57BL/6) OHSC at DG, pS129-positive aggregates of mouse α-syn were detectable 3 days post injection (dpi). It started as short, serpentine-like inclusions with a diameter of about 0.06 µm (Figs. 1, e,i) . The pS129 positive structures were also positive for the aggregate-specific MJF-14 antibody. By 5 dpi, these structures appeared to coalesce into longer serpentine structures, while at 7 dpi, fibrillar aggregates were detected in the cell body around the nucleus (Fig. 1,e, ii,iii). The aggregates located in the cell bodies resembled those observed by IHC in the hypothalamic region of an end-stage hA53T α-syn transgenic mice (Fig. 1,i) .
The pS129-positive aggregates in slices were located in axons and neuronal cell bodies as evidenced by their colocalization with the subcellular markers neurofilament light chain and NeuN (Fig. 1,f,g) . Upon extraction and western blotting of PFF-injected slices, it was evident that pS129-positive insoluble α-syn species became detectable after 7 days and increased at 14 days. The results demonstrate that endogenous α-syn is converted into insoluble species phosphorylated at Ser129 upon seeding with PFF ( Fig. 1,k) .
Superresolution microscopy revealed the axonal pS129-positive inclusions consisted of smaller structures of more intense immunoreactivity suggestive of discrete α-syn inclusions filling or being moved within the axon (Fig. 1,j) .
Injection of monomeric α-syn into WT slices or injection of S129A-PFFs into slices made from α-syn KO pups induced no aggregation at 7 dpi (Fig. 2,a,i ,ii). This shows that the aggregation process depends on preformed fibrillar seeds and presence of endogenous α-syn.
Application 1: Demonstrating S129A-PFF templated α-syn aggregation spreads by interneuronal processes from the DG region via CA3 to CA1 region.
Seeded aggregation of endogenous α-syn in the DG regions was observed after 3 dpi, but the first interneuronal spreading from DG to the CA3 and CA1 regions appeared as axonal inclusions after 5 to 7 days (Fig. 2,b ). Neuronal cell body inclusions became detectable after 2 weeks in CA1 region ( Supplementary Fig. 2) , that in comparison to the aggregates found in the cell bodies of DG, were more compacted as spherical cytoplasmic inclusion with immunoreactivity to both pS129 and MJF-14 antibodies, suggesting the development of Lewy body-like inclusion at this stage in the culture (Fig. 2, e   & Supplementary fig.3 ). Both seeding and spreading developed more quickly and became more prominent when the endogenous α-syn level was increased, as demonstrated in slices from mThy-1-human-α-syn transgenic pups, where cell body inclusions were detected at the CA1 region by 7dpi (Fig. 2,c,d ).
Microinjection of PFFs was essential for the ordered interneuronal spread of PFF-templated aggregation from DG to CA3 and CA1, because application of PFF solution to the surface of the slice resulted in development of pS129-positive structures predominantly in the periphery of the slice (Supplementary fig.   4 ). This pattern is most likely caused by fluid flow across the slice surface.
Having established that seeded α-syn aggregate pathology can spread anterograde from the DG to the CA1 region in the hippocampal slice model, we wanted to determine if retrograde spreading from the CA1 to the DG region also could occur. When slices were injected with S129A-PFFs in the CA1 region, pS129-positive aggregates were observed at CA1 and in the area between CA1 and CA3 after 10 days, but no aggregates were found at DG suggesting retrograde spreading is less efficient compared to the anterograde spreading ( Fig. 3,a, 
i,ii,iii).
To test the hypothesis that the identified interneuronal spreading is trans-synaptic in the slice model, a surgical cut was made in the region between DG and CA3 through the whole thickness of the slice immediately after PFF injection. This would block the axonal transport required for spreading through the synaptically connected DG and CA3 regions. Loss of axonal connectivity between DG and CA3 in the slice blocked the formation of the MJF14-and pS129-positive aggregates distal to the lesion compared with control slices with an intact connection through the DG-CA3-CA1 regions of the slice (Fig. 3,b) .
True trans-synaptic spreading of templated α-syn aggregate pathology requires expression of endogenous α-syn in all the connected neurons as α-syn is required to amplify the small amount of seeds taken up by receiving neurons to facilitate further release of new seeds to the next neuron in the pathway.
To investigate this hypothesis, we used α-syn KO slices that do not allow development of pathology upon PFF injection (Fig. 2, a,i) . In these slices, human α-syn was expressed in neurons by AAV vector driven by the synapsin1 promoter at all DG, CA3 and CA1 regions (Fig. 3, c) . Successful expression was confirmed with immunostaining of AAV injected slices using total α-syn (MJFR1) and pS129 antibodies.
α-syn and pS129 expressing neurons were detected at the targeted regions with pS129 positive diffuse nuclei and cell bodies whereas MJFR1 staining revealed α-syn was efficiently sorted to punctate-structures reminiscent of nerve terminals ( Supplementary Fig. 5, a, i & ii) . pS129 antibody were used for detection of 129A PFF induced aggregates. These more pale signals are clearly distinct from the brighter inclusions that evolved upon injection of PFF (Fig. 3, c ,i,ii,iii).
Injection of α-syn-expressing vectors in the DG, CA3, and CA1 regions of the KO slice allowed interneuronal spreading of α-syn aggregate pathology from the PFF injection site in the DG to the synaptically connected CA3 and CA1 regions (Fig. 3, c ,i,ii,iii) as observed in wild type hippocampal slices ( Fig. 2, b) . The pathology progressed further by 14 dpi, with the perinuclear pS129-positive aggregates found in the CA1 region ( Supplementary fig. 5, b) , as discussed for wild type slices injected with PFFs.
To abrogate the hypothesized sequential trans-synaptic spreading from neurons in DG to CA3 and then CA1, we only injected the human α-syn-expressing AAV vector into the DG and CA1 regions but not in the CA3 neurons, to leave CA3 region without any α-syn expression ( Fig. 3, d) . No spreading to the CA1 region was detectable by 7 dpi upon injection of S129A PFF into the DG region, although a prolific pS129positive aggregation developed in the DG region ( Fig. 3, d , i, ii, iii) . Even at 14dpi, no pathology was detectable in the CA1 region, showing only the diffuse nuclear staining ( Supplementary Fig. 5, c) . This supports the hypothesis of sequential trans-synaptic spreading of α-syn aggregate pathology.
Application 2: Using organotypic hippocampal slices from α-syn KO mice and AAV vectors to demonstrate α-syn aggregation and spreading occur independently of its phosphorylation on Ser-
129.
Phosphorylation of serine-129 in α-syn represents a hallmark for pathological α-syn inclusions in the human brain. However, its pathophysiological role is contested with respect to its role in aggregation and cytotoxicity (Gorbatyuk et al., 2008) , (McFarland et al., 2009 ) , (Chen & Feany, 2005) . To investigate the role of this post-translational modification in the trans-synaptic spreading of seeded α-syn aggregation using the new model, we expressed a non-phosphorylatable S129G mutant and wt α-syn using AAV vectors in α-syn KO slices, and compared the spreading of MJF-14 positive aggregates for both variants (Fig. 4,   a) . S129G and wt α-syn were expressed at comparable levels in the KO slices as determined by immunoblotting, but only the wt protein was as expected phosphorylated on S129 (Fig. 4, b) . Both transgenes supported the development of MJF-14 positive aggregates in the DG regions that spread to the CA1 region when S129A-PFFs were injected into the DG (Fig. 4, c, d) . However, only the wt form of αsyn was phosphorylated at S129 ( Fig. 4, e, f) . The S129 phosphorylated and non-phosphorylable aggregates appeared comparable with respect to axonal and cell body localization. It can thus be concluded that phosphorylation of S129 in α-syn is not critical for interneuronal spreading of the templated aggregates pathology. The organotypic hippocampal slice model is thus a versatile tool that allows investigation of the role of site-specific post-translational modification in spreading of seeded α-syn in a time and costscale that is much smaller than if one had to develop transgenic animal models on an α-syn KO background.
Discussion
The correlation of PD symptomatology with the progression of the pathological α-syn aggregatecontaining Lewy bodies formed the basis for the Braak hypothesis (Braak et al., 2003) . This hypothesis was corroborated by the demonstration of Lewy body pathology in fetal neurons transplanted into the striatum of PD patients 11-16 years prior to their death (Brundin, Melki, & Kopito, 2010) . Since then, the general hypothesis of a prion-like spreading of templated misfolded proteins that comprised diseases like Creutzfeldt-Jakob disease and Alzheimer's disease was expanded to include other disease as PD, dementia with Lewy bodies (DLB), and multiple systems atrophy (MSA), where seeds of aggregated α-syn are considered the culprit (Jucker & Walker, 2018) , (Aguzzi, Baumann, & Bremer, 2008) , (Prusiner et al., 2015) .
In vivo models of seeded α-syn aggregation are slow and costly, and in vitro cell-based models developed to facilitate mechanistic investigation and drug screening lack the complexity of nervous tissue (Gribaudo et al., 2019) , (Volpicelli-Daley, Luk, & Lee, 2014) , (Smits et al., 2019) .
In this article, we present a novel ex vivo brain tissue culture model that can serve as a translational step between cell-based and in vivo models. The model takes advantage of the organotypic hippocampal slice culture that for decades has been used for electrophysiological analyses (Dunwiddie & Lynch, 1978) . It possesses three synaptically connected neuronal populations located in a developmentally evolved brain 13 structure embedded in an active matrix of glia cells, and it is thus outperforms currently available two-and even three-dimensional in vitro culture systems (Smits et al., 2019) , (Amin & Paşca, 2018) . The model is based on microinjection of α-syn PFFs into the DG. PFFs seed a progressive, templated aggregation of endogenous mouse α-syn that spreads through CA3 to CA1 neurons. Application of the PFFs by microinjection is critical for the model because simple application of PFFs on top of the slice only induced development of aggregatecontaining neurons in the periphery of the slice and not the interconnected neurons of the DG, CA3, and CA1 circuit.
The use of S129A-PFF, which cannot be phosphorylated at S129, and detection of cellular aggregates by pS129-α-syn antibody allowed the unequivocal conclusion that inclusions formed in the tissue were made de novo and do not merely represent the injected material. These inclusions shared the disease-associated epitopes with aggregates present in human brain affected by synucleinopathies as demonstrated by the binding of pS129-α-syn antibodies and the conformation-specific α-syn aggregate antibody MJF-14 (Sampson et al., 2018) . The PFF induced inclusions had demonstrated different patterns that were topology-and timedependent (Supplementary fig. 3 ). Interestingly, the aggregates observed at DG by 7 and 14 dpi resembled filamentous structures that wrapped the nucleus. However, more compacted, often spherical, cytoplasmic inclusions developed in CA1 region at 14dpi, suggesting Lewy body-like inclusions can development in this region. This concurs with findings demonstrating Math2 expressing neurons in the CA1 were more affected by α-syn pathology following seeding with PFFs in vivo, in contrast to DG neurons, which are relatively spared (Luna et al., 2018) .
No pathology developed when PFFs were injected in α-syn KO slices. This demonstrates that neuronal α-syn expression is essential for the templating of α-syn aggregate pathology in the model in accordance with previous in vivo models (Luk et al., 2012) .
In agreement with the previous finding that the development and progression of α-syn pathology in humans depends on the level of α-syn expression, where faster disease progression in patients with duplications and triplications of the α-syn-encoding SNCA gene was reported (Konno, Ross, Puschmann, Dickson, & Wszolek, 2016) , (Singleton et al., 2003) , the development and progression of α-syn in the hippocampal slice model were enhanced in slices from α-syn-transgenic pups compared with wild type pups. .
The directionality of the pathology spreading remains unclear because of the complex spreading pattern observed in the brain after inoculation of seeds in the striatum, hippocampus or olfactory bulb (Rey et al., 2018) , (Masuda-Suzukake et al., 2013) . However, a component of retrograde axonal transport is likely to transfer seeds from the gut to the vagal nucleus, as demonstrated in rodents (Holmqvist et al., 2014) . We used the model to answer the question of whether there is a preferred direction of spreading of templated aggregation in hippocampal tissue by comparing the spreading upon injection of PFF into the DG or CA1.
Anterograde transfer from the DG to the CA1 region was the preferred mode, as demonstrated by the absence of spreading from the CA1 region to the DG after 10 days despite florid local templating of α-syn to an aggregated form at the CA1 region. The hypothesis of anterograde trans-synaptic spreading was corroborated by the fact that spreading was blocked by cutting the axons in the CA3 region. To demonstrate spreading not only requires an intact synaptic connection but also a sufficient level of α-syn expression to allow a seeding dependent aggregate formation. We therefore used hippocampal slices from α-syn KO pups in which neuronal α-syn expression was established locally using AAV vector. The α-syn KO slices were only able to support templated spreading from DG to CA1 when human α-syn expression was established in all connected regions, DG, CA3, and CA1. Inversely, no spreading occurred if the slices lacked α-syn expression at the CA3 region.
This experiment also demonstrates that templated aggregation in the CA1 region is due to a transfer of templated pathological α-syn aggregates through the circuit, which requires renewed templating in each recipient population and not just a transfer of injected PFF through the circuit The viral vector approach to the expression and silencing of genes of interest makes our slice model a versatile tool for constructing tailor-made slices where candidate genes are modulated. As proof of concept, we asked if phosphorylation on S129 is necessary for seeded aggregation and spreading in brain tissue because this post-translational modification represents a biomarker of aberrant α-syn aggregates in cells and tissue. To answer this question, we used AAV vector to reconstitute expression of WT and non-phosphorylatable S129G mutant human α-syn in α-syn KO slices and injected them with PFFs in the DG region. The successful production of a slice solely expressing S129G α-syn allowed us to conclude that phosphorylation at S129 was not a prerequisite for initiation of α-syn aggregation or its interneuronal spreading. The approach of transgenic expression of α-syn species in KO tissue can be extended to investigate the role of other post-translational αsyn modifications like truncations, ubiquitinations on specific lysines, or N-terminal acetylation; and it can be used for validating proteins involved in spreading process.
The model has some limitations; firstly, anatomic variations among individually cultivated slices sectioned through the small hippocampal structure can pose a challenge. However, random selection and increasing the number of slices used per experiment can overcome the influence of this variation in the final results.
Secondly, the sparse induction of aggregates by PFFs in only certain neurons when wild type slices are used makes it more difficult to study the conspicuous toxicity of aggregates in slices densely packed with neurons but may also open for studying the effect of different α-syn aggregate strains on uptake, seeding, and spreading. It may also make it possible to address factors governing selective neuronal vulnerability and thus resemble in vivo conditions in the sick brain, where only vulnerable neurons rather than the whole population show synuclein pathology.
Conclusion
This study presents a novel ex vivo brain tissue model for studying seeded α-syn aggregation and interneuronal spreading in circuitry-connected neurons. This model is superior to previous in vitro models with regard to replicating the hypothesized pathophysiologic neuronal handling of α-syn aggregates as only the first recipient neurons in DG are challenged by in vitro formed aggregates. The further spreading of seeding competent species represents novel in cellulo generated aggregates as demonstrated by the absence of aggregates in slices from synuclein α-syn KO slices and the absence of spreading from DG to CA1 when no α-syn was expressed in the CA3 neurons. These underlying mechanisms may thus be operating in diseases like PD, Lewy body dementia, and Alzheimer's disease, which exhibits significant Lewy body accumulation.
The speed by which the spreading occurs combined with the ability to manipulate the model genetically by using hippocampal tissue of pups from transgenic mouse lines and AAV viral vector allows for testing a host of pro-and anti-degenerative genes including risk genes identified by GWAS studies. With respect to posttranslational modifications, we established that phosphorylation at S129 not is a prerequisite for aggregation or spreading in mouse tissue. It is thus an innovative alternative to transgenic animals, being significantly easier, faster, and less costly; most importantly, it is well in line with the "3R" concept values, replacement, reduction and refinement, regarding use of animals in experiments. It also provides opportunities for novel, attractive, and beneficial applications based on using different genetic mouse lines, viral vectorbased gene regulation, super-resolution microscopy, live imaging and electrophysiological recording, and pharmacological treatment. Despite not being phosphorylated on S129, expression of S129G-α-syn still supports establishment of MJF-14-positive aggregate pathology in the DG, scale bar=50µm that i, is present in axons (arrow) and cell bodies (arrow head), scale bar=20 µm. f, This nonphosphorylated aggregate α-syn pathology spreads to the CA1 region, scale bar= 50 µm. Images are representative of more than 5 experiments.
